Literature DB >> 15189039

Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high-energy intermediate and transition-state analogues.

Christophe Dardonville1, Eliana Rinaldi, Michael P Barrett, Reto Brun, Ian H Gilbert, Stefania Hanau.   

Abstract

Two series of compounds were designed to mimic the transition state and high-energy intermediates (HEI) of the enzymatic reaction of 6-phosphogluconate dehydrogenase (6PGDH). Sulfoxide analogues (7-11) were designed to mimic the transition state during the oxidation of the substrate to 3-keto-6-phosphogluconate, an enzyme-bound intermediate of the enzyme. Hydroxamate and amide derivatives of d-erythronic acid were designed to mimic the 1,2-cis-enediol HEI of the 6PGDH reaction. These two series of compounds were assayed as competitive inhibitors of the Trypanosoma brucei and sheep liver enzymes, and their selectivity value (ratio sheep/parasite) was calculated. The sulfoxide transition-state analogues showed weak and selective inhibition of the T. brucei enzyme. The hydroxamic derivatives showed potent and selective inhibition of the T. brucei 6PGDH with a Ki in the nanomolar range.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15189039     DOI: 10.1021/jm031066i

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Crystal structures of a bacterial 6-phosphogluconate dehydrogenase reveal aspects of specificity, mechanism and mode of inhibition by analogues of high-energy reaction intermediates.

Authors:  Ramasubramanian Sundaramoorthy; Jorge Iulek; Michael P Barrett; Olivier Bidet; Gian Filippo Ruda; Ian H Gilbert; William N Hunter
Journal:  FEBS J       Date:  2007-01       Impact factor: 5.542

2.  Use of a scaffold peptide in the biosynthesis of amino acid-derived natural products.

Authors:  Chi P Ting; Michael A Funk; Steve L Halaby; Zhengan Zhang; Tamir Gonen; Wilfred A van der Donk
Journal:  Science       Date:  2019-07-19       Impact factor: 47.728

3.  Virtual fragment screening for novel inhibitors of 6-phosphogluconate dehydrogenase.

Authors:  Gian Filippo Ruda; Gordon Campbell; Vincent P Alibu; Michael P Barrett; Ruth Brenk; Ian H Gilbert
Journal:  Bioorg Med Chem       Date:  2010-06-09       Impact factor: 3.641

4.  Aryl phosphoramidates of 5-phospho erythronohydroxamic acid, a new class of potent trypanocidal compounds.

Authors:  Gian Filippo Ruda; Pui Ee Wong; Vincent P Alibu; Suzanne Norval; Kevin D Read; Michael P Barrett; Ian H Gilbert
Journal:  J Med Chem       Date:  2010-08-26       Impact factor: 7.446

5.  Ribose 5-phosphate isomerase B knockdown compromises Trypanosoma brucei bloodstream form infectivity.

Authors:  Inês Loureiro; Joana Faria; Christine Clayton; Sandra Macedo-Ribeiro; Nuno Santarém; Nilanjan Roy; Anabela Cordeiro-da-Siva; Joana Tavares
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08

Review 6.  6-Phosphogluconate dehydrogenase and its crystal structures.

Authors:  Stefania Hanau; John R Helliwell
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2022-02-23       Impact factor: 1.056

7.  Metabolic flexibilities and vulnerabilities in the pentose phosphate pathway of the zoonotic pathogen Toxoplasma gondii.

Authors:  Ningbo Xia; Xuefang Guo; Qinghong Guo; Nishith Gupta; Nuo Ji; Bang Shen; Lihua Xiao; Yaoyu Feng
Journal:  PLoS Pathog       Date:  2022-09-19       Impact factor: 7.464

8.  Synthesis and biological evaluation of phosphate prodrugs of 4-phospho-D-erythronohydroxamic acid, an inhibitor of 6-phosphogluconate dehydrogenase.

Authors:  Gian Filippo Ruda; Vincent P Alibu; Christos Mitsos; Olivier Bidet; Marcel Kaiser; Reto Brun; Michael P Barrett; Ian H Gilbert
Journal:  ChemMedChem       Date:  2007-08       Impact factor: 3.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.